THE BUSINESS OF BIOTECH

BoB@JPM: Ran Zheng, Landmark Bio
Ran Zhang was hire number one at Landmark Bio back in 2021. Today, she's CEO of the 70+ employee cell and gene therapy manufacturer. We caught up with her and Life Science Leader chief editor Ben Comer at the JP Morgan Healthcare Conference in San Francisco for a disc...
ABOUT THE BUSINESS OF BIOTECH
Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.
FEATURED GUESTS

Ran Zheng

Peter Anastasiou

Stefan Scherer

Jim Doherty

Andrey Doronichev

Jeff Coller

Michelle Kim

Tal Zaks

Alexandria Forbes

Vikram Bajaj
MEET THE HOST
Hosted by Bioprocess Online Chief Editor Matt Pillar, The Business of Biotech brings you weekly intelligence and insight, from leading voices in the biotech industry.
Interested in joining us on air? Contact us
RECENT EPISODES
